chr4-109869931-ATCT-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2
The NM_198506.5(LRIT3):c.1187_1189delCTT(p.Ser396del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0356 in 1,613,796 control chromosomes in the GnomAD database, including 1,130 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 79 hom., cov: 32)
Exomes 𝑓: 0.036 ( 1051 hom. )
Consequence
LRIT3
NM_198506.5 disruptive_inframe_deletion
NM_198506.5 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.736
Genes affected
LRIT3 (HGNC:24783): (leucine rich repeat, Ig-like and transmembrane domains 3) This gene encodes a protein that has a fibronectin type III domain and a C-terminal transmembrane domain, as well as a leucine-rich repeat domain and immunoglobulin-like domain near the N-terminus. The encoded protein may regulate fibroblast growth factor receptors and affect the modification of these receptors, which are glycosylated differently in the Golgi and endoplasmic reticulum. Mutations in this gene are associated with congenital stationary night blindness, type 1F. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_198506.5
BP6
Variant 4-109869931-ATCT-A is Benign according to our data. Variant chr4-109869931-ATCT-A is described in ClinVar as [Likely_benign]. Clinvar id is 197394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0271 (4120/151978) while in subpopulation NFE AF= 0.0391 (2656/67916). AF 95% confidence interval is 0.0379. There are 79 homozygotes in gnomad4. There are 1962 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 79 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRIT3 | NM_198506.5 | c.1187_1189delCTT | p.Ser396del | disruptive_inframe_deletion | 4/4 | ENST00000594814.6 | NP_940908.3 | |
LRIT3 | XM_017008167.2 | c.638_640delCTT | p.Ser213del | disruptive_inframe_deletion | 3/3 | XP_016863656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRIT3 | ENST00000594814.6 | c.1187_1189delCTT | p.Ser396del | disruptive_inframe_deletion | 4/4 | 5 | NM_198506.5 | ENSP00000469759.1 | ||
LRIT3 | ENST00000327908.3 | c.638_640delCTT | p.Ser213del | disruptive_inframe_deletion | 4/4 | 2 | ENSP00000328222.3 |
Frequencies
GnomAD3 genomes AF: 0.0271 AC: 4121AN: 151860Hom.: 79 Cov.: 32
GnomAD3 genomes
AF:
AC:
4121
AN:
151860
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0269 AC: 6747AN: 250848Hom.: 120 AF XY: 0.0277 AC XY: 3759AN XY: 135688
GnomAD3 exomes
AF:
AC:
6747
AN:
250848
Hom.:
AF XY:
AC XY:
3759
AN XY:
135688
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0365 AC: 53295AN: 1461818Hom.: 1051 AF XY: 0.0359 AC XY: 26098AN XY: 727204
GnomAD4 exome
AF:
AC:
53295
AN:
1461818
Hom.:
AF XY:
AC XY:
26098
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0271 AC: 4120AN: 151978Hom.: 79 Cov.: 32 AF XY: 0.0264 AC XY: 1962AN XY: 74304
GnomAD4 genome
AF:
AC:
4120
AN:
151978
Hom.:
Cov.:
32
AF XY:
AC XY:
1962
AN XY:
74304
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 17, 2014 | - - |
Congenital Stationary Night Blindness, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at